SCIENTURE HOLDINGS, INC.

SCNX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $431.6K $136.6K $1.4M $10.3M $9.9M $17.1M $7.4M $3.8M
Cost of Revenue $100.1K $130.6K $1.3M $4.7M $5.1M $11.4M $2.6M $449.0K
Gross Profit $331.5K $6.0K $49.0K $5.5M $4.7M $5.7M $4.9M $3.4M
Gross Margin 76.8% 4.4% 3.6% 53.8% 48.0% 33.3% 65.5% 88.3%
Operating Expenses
Research & Development $2.0M $2.2M
SG&A Expense $7.9M $6.7M $1.3M $1.7M $1.9M $7.5M $4.4M $3.5M
Operating Income $-42.6M $-14.7M $-4.4M $-2.9M $-5.3M $-2.5M $125.2K $-87.6K
Operating Margin -9,867.9% -10,758.7% -322.4% -28.4% -53.5% -14.6% 1.7% -2.3%
Interest Expense $1.2M $336.2K $23.6K $29.4K $53.2K $57.5K
Pretax Income $-43.5M $-18.8M $-8.5M
Income Tax Expense $-2.0M $-534.4K
Net Income $-41.5M $9.1M $-17.8M $-3.5M $-5.3M $-2.5M $-284.4K $9.0K
Net Margin -9,618.0% 6,634.7% -1,308.3% -33.9% -53.8% -14.8% -3.8% 0.2%
EPS (Basic) $-2.70 $0.67 $-5.84 $-0.38 $-0.04 $-0.02 $0.00 $0.00
EPS (Diluted) $-2.70 $0.62 $-5.84 $-0.38 $-0.04 $-0.02 $0.00 $0.00
Shares Outstanding (Basic) 15.3M 13.5M 3.1M 9.0M 130.2M 129.5M 94.9M 86.0M
Shares Outstanding (Diluted) 15.3M 14.6M 9.5M 9.1M 130.2M 129.5M 94.9M 93.2M
Dividends Per Share
← Newer Page 1 of 2 Older →